MetaCap

USANA Health Sciences Inc. (USNA)

NYSE: USNAHealth Care Medicinal Chemicals and Botanical Products USD

12.94-0.22 (-1.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

USNA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$239.24M
EPS (TTM)
-$1.14
52-week range
12.53 – 23.59
Day range
12.88 – 13.43
Volume / Avg
158.78K / 194.10K
Beta
—

52-week range

$12.53$23.59

USNA stock today

USANA Health Sciences (USNA) closed at $12.94 on Nov 20, down 1.67% (-$0.22), versus the S&P 500's 3.70% decline. Shares are 45.1% below their 52-week high of $23.59, set on Jul 28, 2026 and 3.3% above the 52-week low of $12.53, near the bottom of the past year's range. USNA is down 34.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 34.1%.

USANA Health Sciences has posted a net loss over the last twelve months (EPS of -$1.14), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About USANA Health Sciences

Company profile

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer.

Industry
Medicinal Chemicals and Botanical Products
CEO
Mr. Kevin G. Guest
Headquarters
Salt Lake City, UT
Employees
1,570
Website
usana.com

Financial highlights

Full financials

In fiscal 2025, USANA Health Sciences generated $925.3 million in revenue, up 8.3% from fiscal 2023. Net income was $10.8 million (-74.4% year over year), for a net margin of 1.2% versus a median of 6.9% in the prior 5 years. Gross margin was 78.3% (down from 81.1%) and operating margin 4.0%.

USANA Health Sciences annual revenue, net income and EPS
Fiscal yearFY 2025FY 2023FY 2023FY 2022FY 2022
Revenue$925.26M$854.50M$921.01M$998.60M$1.19B
Growth+8.28%-7.22%-7.77%-15.83%+4.57%
Net income$10.76M$42.03M$63.79M$69.35M$116.50M
EPS (diluted)$0.58$2.19$3.30$3.59$5.73

Analyst forecast

Forecast

Consensus

none

Avg. price target

$22.00+70.02%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$-0.15 vs $0.11
Surprise
-236.36%

USNA news

All USNA news

USANA Health Sciences peers

Health Care sector
USNA peer companies
CompanyPrice% ChgMarket capCompare
ACBAurora Cannabis Inc.4.16-2.35%$273.50Mvs USNA
TLRYTilray Brands Inc.1.89-8.70%$279.32Mvs USNA
SNDLSNDL Inc.1.17-5.65%$285.20Mvs USNA
MDWDMediWound Ltd.13.59+0.37%$195.56Mvs USNA
CGCCanopy Growth Corporation0.427-9.97%$191.99Mvs USNA
NAGENiagen Bioscience Inc.1.84-1.60%$145.72Mvs USNA
GLASGlass House Brands Inc. Subordinate Voting Shares1.18-2.48%$118.11Mvs USNA
ISPRIspire Technology Inc.1.23-3.15%$71.05Mvs USNA

Indexes, lists and sector

USANA Health Sciences stock FAQ

What is USANA Health Sciences's stock price today?

USNA last traded at $12.94 as of Nov 20, 4:00 PM EST, down 1.67% on the day. Prices are delayed at least 15 minutes.

Does USANA Health Sciences pay a dividend?

No. USANA Health Sciences does not currently pay a regular cash dividend.

Who is USANA Health Sciences's CEO?

Mr. Kevin G. Guest is the chief executive officer of USANA Health Sciences Inc., which has about 1,570 employees.

Has USNA ever split its stock?

Yes. The most recent USNA stock split was a 2-for-1 split on Nov 23, 2016, one of 3 splits on record.

What is the USNA 52-week high?

The 52-week high for USNA is $23.59 and the 52-week low is $12.53. The stock is currently 45.1% below its high.

Compare USNA